Market Research Logo

Global Cardiac Biomarkers Market 2017-2021

Global Cardiac Biomarkers Market 2017-2021

About Cardiac Biomarkers

Cardiac biomarkers are the substances used to detect the risk stratification of a patient with chest pain or suspected acute coronary syndrome (ACS). These biomarkers are released in blood when the heart is damaged or stressed. The tests that are carried out by introducing the cardiac biomarkers to the bloodstream help in determining the risks of associated heart conditions such as cardiac ischemia, ACS, myocardial infarction, and other associated heart diseases.

Technavio’s analysts forecast the global cardiac biomarkers market to grow at a CAGR of 12.97% during the period 2017-2021.

Covered in this report

The report covers the present scenario and the growth prospects of the global cardiac biomarkers market for 2017-2021. The report presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA
Technavio's report, Global Cardiac Biomarkers Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
  • Abbott
  • Alere
  • F. Hoffmann-La Roche
Other prominent vendors
  • Advanced ImmunoChemical
  • AgPlus Diagnostics
  • AZSense
  • BD
  • BG Medicine
  • BioLegend
  • bioMérieux
  • Bio-Rad Laboratories
  • BODITECH MED
  • CAVADIS
  • Cisbio Bioassays
  • Creative Diagnostics
  • Critical Diagnostics
  • Cruinn Medical
  • DiaDexus
  • Enzo Life Sciences
  • Lepu Medical
  • LifeSign
  • LSI Medience
  • Merck
  • Monobind
  • Myriad RBM
  • NeoClone
  • NOWDiagnostics
  • Olink
  • Randox Laboratories
  • Response Biomedical
  • Signosis
  • Thermo Fisher Scientific
  • Tosoh Europe
  • Trinity Biotech
  • Trivitron Healthcare
  • Wondfo
Market driver
  • Increasing use of cardiac biomarkers
  • For a full, detailed list, view our report
Market challenge
  • Dominance of top vendors
  • For a full, detailed list, view our report
Market trend
  • Increased clinical trials
  • For a full, detailed list, view our report
Key questions answered in this report
  • What will the market size be in 2021 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?


Press Release

Technavio Announces the Publication of its Research Report – Global Cardiac Biomarkers Market 2017-2021

Technavio recognizes the following companies as the key players in the global cardiac biomarkers market: Abbott, Alere, and F. Hoffmann-La Roche.

Other Prominent Vendors in the market are: Advanced ImmunoChemical, AgPlus Diagnostics, AZSense, BD, BG Medicine, BioLegend, bioMérieux, Bio-Rad Laboratories, BODITECH MED, CAVADIS, Cisbio Bioassays, Creative Diagnostics, Critical Diagnostics, Cruinn Medical, DiaDexus, Enzo Life Sciences, Lepu Medical, LifeSign, LSI Medience, Merck, Monobind, Myriad RBM, NeoClone, NOWDiagnostics, Olink, Randox Laboratories, Response Biomedical, Signosis, Thermo Fisher Scientific, Tosoh Europe, Trinity Biotech, Trivitron Healthcare, and Wondfo.

Commenting on the report, an analyst from Technavio’s team said: “One trend in the market is increased clinical trials. There is an increasing number of clinical trials for cardiac biomarkers. Manufacturers, universities, and research institutes are conducting various clinical trials to prove the efficacy of cardiac biomarkers. The increase in proficiency and accurate results of the cardiac biomarkers provide a high demand for them in the market.”

According to the report, one driver in the market is increasing use of cardiac biomarkers. The use of cardiac biomarkers helps in assessing the risk associated with diabetes, which invariably affects the cardiovascular system of the individual. It also helps in providing the rapid and accurate diagnosis for critically ill patients with presumed ACS. This induces the high adoption of cardiac biomarkers among the end-users to treat people with various cardiac diseases. Based on the study conducted by Universidade Federal do Rio Grande do Sul and associated hospitals in 2017, the people with type 2 diabetes are observed to be having cardiovascular risks as well.

Further, the report states that one challenge in the market is dominance of top vendors. The high market share of the top players such as Abbott, Alere, and F. Hoffmann La-Roche creates a market barrier for the small companies as well as the startups. There is a tendency of small start-ups getting acquired by the top manufacturers, which prevents them from establishing their business in the market. The hurdles faced by the small market players and the start-ups are mainly the budget constraints, innovative products, less number of clinical trials to prove the efficiency of the product, and brand image.

Companies Mentioned

Abbott, Alere, F. Hoffmann-La Roche, Advanced ImmunoChemical, AgPlus Diagnostics, AZSense, BD, BG Medicine, BioLegend, bioMérieux, Bio-Rad Laboratories, BODITECH MED, CAVADIS, Cisbio Bioassays, Creative Diagnostics, Critical Diagnostics, Cruinn Medical, DiaDexus, Enzo Life Sciences, Lepu Medical, LifeSign, LSI Medience, Merck, Monobind, Myriad RBM, NeoClone, NOWDiagnostics, Olink, Randox Laboratories, Response Biomedical, Signosis, Thermo Fisher Scientific, Tosoh Europe, Trinity Biotech, Trivitron Healthcare, and Wondfo.

  • Executive summary
  • Scope of the report
  • Research Methodology
  • Introduction
    • Market outline
      • Table Advantages associated with cardiac biomarkers
  • Market landscape
    • Market overview
      • Table Market overview of global cardiac biomarkers market 2016
    • Market size and forecast
      • Table Global cardiac biomarkers market 2016-2021 ($ millions)
    • Five forces analysis
      • Table Five forces analysis
  • Market segmentation by technology
    • Market overview
      • Table Overview of global cardiac biomarkers market by technology 2016
    • Conventional laboratory testing
      • Table Global cardiac biomarkers market by conventional laboratory testing 2016-2021 ($ millions)
    • POC testing
      • Table Global cardiac biomarkers market by POC testing 2016-2021 ($ millions)
  • Market segmentation by product
    • Market overview
      • Table Overview of global cardiac biomarkers market by product 2016
    • Global troponin (cTnI, cTnT) assay market
      • Table Global troponin (cTnI, cTnT) assay market 2016-2021 ($ millions)
    • Global others assay market
      • Table Global others assay market 2016-2021 ($ millions)
    • Global BNP & NT-proBNP assay market
      • Table Global BNP & NT-proBNP assay market 2016-2021 ($ millions)
    • Global CK-MB assay market
      • Table Global CK-MB assay market 2016-2021 ($ millions)
    • Global myoglobin assay market
      • Table Global myoglobin assay market 2016-2021 ($ millions)
  • Market segmentation by end-user
    • Market overview
      • Table Overview and strategy of global cardiac biomarkers market by end-users 2016
    • Hospitals and clinics
    • Diagnostic laboratories
      • Table Buying criteria of end-users in global cardiac biomarkers market 2016
  • Geographical segmentation
    • Market overview
      • Table Global cardiac biomarkers market by geography 2016 and 2021
    • Cardiac biomarkers market in Americas
      • Table Overview of cardiac biomarkers market in Americas
      • Table Cardiac biomarkers market in Americas 2016-2021 ($ millions)
    • Cardiac biomarkers market in EMEA
      • Table Overview of cardiac biomarkers market in EMEA
      • Table Cardiac biomarkers market in EMEA 2016-2021 ($ millions)
    • Cardiac biomarkers market in APAC
      • Table Overview of cardiac biomarkers market in APAC
      • Table Cardiac biomarkers market in APAC 2016-2021 ($ millions)
  • Decision framework
  • Drivers and challenges
    • Market drivers
      • Table Market analysis for the increasing cardiac diseases worldwide
    • Market challenges
      • Table Average cost of cardiac biomarkers
  • Market trends
    • Increased clinical trials
      • Table Clinical trials and their impact
    • Increasing use of cardiac biomarkers in POC testing
    • Emerging cardiac biomarkers
  • Vendor landscape
    • Competitive landscape
      • Table Competitive structure analysis of global cardiac biomarkers market 2016
      • Table Market penetration of various cardiac biomarkers providers 2016
      • Table Strategic success factors of companies in global cardiac biomarkers market 2016
    • Abbott
      • Table Abbott: Strength assessment
      • Table Abbott: Strategy assessment
      • Table Abbott: Opportunity assessment
    • Alere
      • Table Alere: Strength assessment
      • Table Alere: Strategy assessment
      • Table Alere: Opportunity assessment
    • F. Hoffmann-La Roche
      • Table F. Hoffmann-La Roche: Strength assessment
      • Table F. Hoffmann-La Roche: Strategy assessment
      • Table F. Hoffmann-La Roche: Opportunity assessment
    • Key companies to watch
      • Table Danaher: Company assessment
      • Table Siemens: Company assessment
    • Other prominent vendors
  • Appendix
    • List of abbreviations
  • Explore Technavio

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report